Conduit Pharmaceuticals has filed a Form 424B3 with the Securities and Exchange Commission (SEC). This form is typically used to register securities in accordance with the SEC's rules and regulations and is a prospectus that discloses important information about the company's securities being offered. The filing indicates that Conduit Pharmaceuticals is preparing to offer securities, although the document does not specify the type or amount of securities to be offered, nor does it provide a date for when this offering is expected to take place.

Conduit Pharmaceuticals has filed a Form 424B3 with the Securities and Exchange Commission (SEC). This form is typically used to register securities in accordance with the SEC's rules and regulations and is a prospectus that discloses important information about the company's securities being offered. The filing indicates that Conduit Pharmaceuticals is preparing to offer securities, although the document does not specify the type or amount of securities to be offered, nor does it provide a date for when this offering is expected to take place.